AST 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGOT 5 9 5 9 I-clinical_variable
) 9 10 9 10 I-clinical_variable
& 11 12 11 12 O
ALT 13 16 13 16 B-clinical_variable
( 17 18 17 18 I-clinical_variable
SGPT 18 22 18 22 I-clinical_variable
) 22 23 22 23 I-clinical_variable
≤ 24 25 24 25 O
2.5 26 29 26 29 B-upper_bound
x 30 31 30 31 I-upper_bound
ULN 32 35 32 35 I-upper_bound

Age 0 3 36 39 B-age
≥ 4 5 40 41 O
18 6 8 42 44 B-lower_bound

Alkaline 0 8 45 53 B-clinical_variable
phosphatase 9 20 54 65 I-clinical_variable
< 21 22 66 67 O
2.5xULN 23 30 68 75 B-upper_bound

Creatinine 0 10 76 86 B-clinical_variable
≤ 11 12 87 88 O
1.5 13 16 89 92 B-upper_bound
mg 17 19 93 95 I-upper_bound
/ 19 20 95 96 I-upper_bound
dL 20 22 96 98 I-upper_bound
-or- 23 27 99 103 O
creatinine 28 38 104 114 B-clinical_variable
clearance 39 48 115 124 I-clinical_variable
≥ 49 50 125 126 O
60 51 53 127 129 B-lower_bound
mL 54 56 130 132 I-lower_bound
/ 56 57 132 133 I-lower_bound
min 57 60 133 136 I-lower_bound

ECOG 0 4 137 141 B-clinical_variable
performance 5 16 142 153 I-clinical_variable
status 17 23 154 160 I-clinical_variable
0 24 25 161 162 B-lower_bound
or 26 28 163 165 O
1 29 30 166 167 B-upper_bound

Hemoglobin 0 10 168 178 B-clinical_variable
> 11 12 179 180 O
9.0g 13 17 181 185 B-lower_bound
/ 17 18 185 186 I-lower_bound
dL 18 20 186 188 I-lower_bound

Locally 0 7 189 196 O
advanced 8 16 197 205 O
pancreatic 17 27 206 216 B-cancer
cancer 28 34 217 223 I-cancer
, 34 35 223 224 O
including 36 45 225 234 O
patients 46 54 235 243 O
defined 55 62 244 251 O
by 63 65 252 254 O
Callery19 66 75 255 264 O
as 76 78 265 267 O
unresectable 79 91 268 280 O
and 92 95 281 284 O
borderline 96 106 285 295 O
resectable 107 117 296 306 O
are 118 121 307 310 O
eligible 122 130 311 319 O
: 130 131 319 320 O

Neutrophils 0 11 321 332 B-clinical_variable
≥ 12 13 333 334 O
1,500 14 19 335 340 B-lower_bound
/ 19 20 340 341 I-lower_bound
mm3 20 23 341 344 I-lower_bound

No 0 2 345 347 O
major 3 8 348 353 B-treatment
surgery 9 16 354 361 I-treatment
within 17 23 362 368 O
3 24 25 369 370 B-upper_bound
weeks 26 31 371 376 I-upper_bound
of 32 34 377 379 O
the 35 38 380 383 O
start 39 44 384 389 O
of 45 47 390 392 O
study 48 53 393 398 O
treatment 54 63 399 408 B-treatment
. 63 64 408 409 O
Patients 65 73 410 418 O
must 74 78 419 423 O
have 79 83 424 428 O
recovered 84 93 429 438 O
from 94 98 439 443 O
the 99 102 444 447 O
side 103 107 448 452 O
effects 108 115 453 460 O
of 116 118 461 463 O
any 119 122 464 467 O
major 123 128 468 473 O
surgery 129 136 474 481 O
at 137 139 482 484 O
the 140 143 485 488 O
start 144 149 489 494 O
of 150 152 495 497 O
study 153 158 498 503 O
treatment 159 168 504 513 O
. 168 169 513 514 O
For 170 173 515 518 O
questions 174 183 519 528 O
on 184 186 529 531 O
if 187 189 532 534 O
a 190 191 535 536 O
surgery 192 199 537 544 O
is 200 202 545 547 O
deemed 203 209 548 554 O
major 210 215 555 560 O
, 215 216 560 561 O
definition 217 227 562 572 O
by 228 230 573 575 O
surgeon 231 238 576 583 O
can 239 242 584 587 O
be 243 245 588 590 O
used 246 250 591 595 O
for 251 254 596 599 O
clarification 255 268 600 613 O
. 268 269 613 614 O
Laparoscopy 270 281 615 626 O
and 282 285 627 630 O
central 286 293 631 638 O
venous 294 300 639 645 O
catheter 301 309 646 654 O
placement 310 319 655 664 O
are 320 323 665 668 O
not 324 327 669 672 O
considered 328 338 673 683 O
major 339 344 684 689 O
surgery 345 352 690 697 O

No 0 2 698 700 O
prior 3 8 701 706 O
chemotherapy 9 21 707 719 B-treatment
for 22 25 720 723 O
pancreatic 26 36 724 734 B-cancer
cancer 37 43 735 741 I-cancer

No 0 2 742 744 O
prior 3 8 745 750 B-cancer
invasive 9 17 751 759 I-cancer
malignancy 18 28 760 770 I-cancer
within 29 35 771 777 O
the 36 39 778 781 O
prior 40 45 782 787 B-upper_bound
two 46 49 788 791 I-upper_bound
years 50 55 792 797 I-upper_bound
. 55 56 797 798 O
However 57 64 799 806 O
, 64 65 806 807 O
patients 66 74 808 816 O
with 75 79 817 821 O
an 80 82 822 824 O
early 83 88 825 830 O
stage 89 94 831 836 O
malignancy 95 105 837 847 O
that 106 110 848 852 O
is 111 113 853 855 O
not 114 117 856 859 O
expected 118 126 860 868 O
to 127 129 869 871 O
require 130 137 872 879 O
treatment 138 147 880 889 B-treatment
in 148 150 890 892 O
the 151 154 893 896 O
next 155 159 897 901 B-upper_bound
2 160 161 902 903 I-upper_bound
years 162 167 904 909 I-upper_bound
( 168 169 910 911 O
such 169 173 911 915 O
as 174 176 916 918 O
early 177 182 919 924 O
stage 183 188 925 930 O
, 188 189 930 931 O
resected 190 198 932 940 O
breast 199 205 941 947 B-cancer
cancer 206 212 948 954 I-cancer
or 213 215 955 957 O
asymptomatic 216 228 958 970 O
prostate 229 237 971 979 B-cancer
cancer 238 244 980 986 I-cancer
) 244 245 986 987 O
are 246 249 988 991 O
eligible 250 258 992 1000 O

Not 0 3 1001 1004 O
pregnant 4 12 1005 1013 B-pregnancy
and 13 16 1014 1017 O
not 17 20 1018 1021 O
nursing 21 28 1022 1029 O

Patients 0 8 1030 1038 O
with 9 13 1039 1043 O
a 14 15 1044 1045 O
history 16 23 1046 1053 O
of 24 26 1054 1056 O
interstitial 27 39 1057 1069 B-chronic_disease
lung 40 44 1070 1074 I-chronic_disease
disease 45 52 1075 1082 I-chronic_disease
, 52 53 1082 1083 O
history 54 61 1084 1091 O
of 62 64 1092 1094 O
slowly 65 71 1095 1101 O
progressive 72 83 1102 1113 O
dyspnea 84 91 1114 1121 B-chronic_disease
and 92 95 1122 1125 O
unproductive 96 108 1126 1138 O
cough 109 114 1139 1144 O
, 114 115 1144 1145 O
sarcoidosis 116 127 1146 1157 B-chronic_disease
, 127 128 1157 1158 O
silicosis 129 138 1159 1168 B-chronic_disease
, 138 139 1168 1169 O
idiopathic 140 150 1170 1180 B-chronic_disease
pulmonary 151 160 1181 1190 I-chronic_disease
fibrosis 161 169 1191 1199 I-chronic_disease
, 169 170 1199 1200 O
pulmonary 171 180 1201 1210 B-chronic_disease
hypersensitivity 181 197 1211 1227 I-chronic_disease
pneumonitis 198 209 1228 1239 I-chronic_disease
or 210 212 1240 1242 O
multiple 213 221 1243 1251 O
allergies 222 231 1252 1261 O
that 232 236 1262 1266 O
in 237 239 1267 1269 O
the 240 243 1270 1273 O
investigator 244 256 1274 1286 O
's 256 258 1286 1288 O
opinion 259 266 1289 1296 O
would 267 272 1297 1302 O
put 273 276 1303 1306 O
the 277 280 1307 1310 O
patient 281 288 1311 1318 O
at 289 291 1319 1321 O
an 292 294 1322 1324 O
increased 295 304 1325 1334 O
risk 305 309 1335 1339 O

Patients 0 8 1340 1348 O
with 9 13 1349 1353 O
active 14 20 1354 1360 B-chronic_disease
infection 21 30 1361 1370 I-chronic_disease
or 31 33 1371 1373 O
fever 34 39 1374 1379 O
( 40 41 1380 1381 O
patients 41 49 1381 1389 O
on 50 52 1390 1392 O
antibiotics 53 64 1393 1404 B-treatment
for 65 68 1405 1408 O
infection 69 78 1409 1418 O
or 79 81 1419 1421 O
patients 82 90 1422 1430 O
getting 91 98 1431 1438 O
over 99 103 1439 1443 O
a 104 105 1444 1445 O
cold 106 110 1446 1450 O
or 111 113 1451 1453 O
seasonal 114 122 1454 1462 O
virus 123 128 1463 1468 O
are 129 132 1469 1472 O
not 133 136 1473 1476 O
excluded 137 145 1477 1485 O
) 145 146 1485 1486 O
, 146 147 1486 1487 O
or 148 150 1488 1490 O
known 151 156 1491 1496 O
historical 157 167 1497 1507 O
or 168 170 1508 1510 O
active 171 177 1511 1517 O
infection 178 187 1518 1527 O
with 188 192 1528 1532 O
HIV 193 196 1533 1536 B-chronic_disease
, 196 197 1536 1537 O
hepatitis 198 207 1538 1547 B-chronic_disease
B 208 209 1548 1549 I-chronic_disease
, 209 210 1549 1550 O
or 211 213 1551 1553 O
hepatitis 214 223 1554 1563 B-chronic_disease
C 224 225 1564 1565 I-chronic_disease

Patients 0 8 1566 1574 O
with 9 13 1575 1579 O
active 14 20 1580 1586 O
sepsis 21 27 1587 1593 B-chronic_disease
or 28 30 1594 1596 O
pneumonitis 31 42 1597 1608 B-chronic_disease

Patients 0 8 1609 1617 O
with 9 13 1618 1622 O
elevated 14 22 1623 1631 O
alkaline 23 31 1632 1640 B-clinical_variable
phosphatase 32 43 1641 1652 I-clinical_variable
, 43 44 1652 1653 O
total 45 50 1654 1659 O
bilirubin 51 60 1660 1669 O
, 60 61 1669 1670 O
AST 62 65 1671 1674 O
and 66 69 1675 1678 O
ALT 70 73 1679 1682 O
, 73 74 1682 1683 O
who 75 78 1684 1687 O
have 79 83 1688 1692 O
subsequently 84 96 1693 1705 O
undergone 97 106 1706 1715 O
biliary 107 114 1716 1723 O
stenting 115 123 1724 1732 O
and 124 127 1733 1736 O
their 128 133 1737 1742 O
liver 134 139 1743 1748 O
tests 140 145 1749 1754 O
are 146 149 1755 1758 O
improving 150 159 1759 1768 O
, 159 160 1768 1769 O
do 161 163 1770 1772 O
not 164 167 1773 1776 O
need 168 172 1777 1781 O
to 173 175 1782 1784 O
wait 176 180 1785 1789 O
for 181 184 1790 1793 O
their 185 190 1794 1799 O
alkaline 191 199 1800 1808 O
phosphatase 200 211 1809 1820 O
to 212 214 1821 1823 O
become 215 221 1824 1830 O
< 222 223 1831 1832 O
2.5x 224 228 1833 1837 B-upper_bound
ULN 229 232 1838 1841 I-upper_bound
if 233 235 1842 1844 O
their 236 241 1845 1850 O
total 242 247 1851 1856 O
bilirubin 248 257 1857 1866 O
, 257 258 1866 1867 O
AST 259 262 1868 1871 O
and 263 266 1872 1875 O
ALT 267 270 1876 1879 O
have 271 275 1880 1884 O
improved 276 284 1885 1893 O
to 285 287 1894 1896 O
within 288 294 1897 1903 O
required 295 303 1904 1912 O
study 304 309 1913 1918 O
levels 310 316 1919 1925 O
and 317 320 1926 1929 O
the 321 324 1930 1933 O
alkaline 325 333 1934 1942 O
phosphatase 334 345 1943 1954 O
is 346 348 1955 1957 O
decreasing 349 359 1958 1968 O
. 359 360 1968 1969 O
) 360 361 1969 1970 O

Patients 0 8 1971 1979 O
with 9 13 1980 1984 O
metastatic 14 24 1985 1995 B-cancer
disease 25 32 1996 2003 I-cancer

Patients 0 8 2004 2012 O
with 9 13 2013 2017 O
pathology 14 23 2018 2027 O
or 24 26 2028 2030 O
cytology 27 35 2031 2039 O
showing 36 43 2040 2047 O
carcinoma 44 53 2048 2057 B-cancer
of 54 56 2058 2060 I-cancer
pancreas 57 65 2061 2069 I-cancer
or 66 68 2070 2072 O
adenosquamous 69 82 2073 2086 B-cancer
of 83 85 2087 2089 I-cancer
the 86 89 2090 2093 I-cancer
pancreas 90 98 2094 2102 I-cancer
are 99 102 2103 2106 O
also 103 107 2107 2111 O
eligible 108 116 2112 2120 O

Patients 0 8 2121 2129 O
with 9 13 2130 2134 O
serious 14 21 2135 2142 O
medical 22 29 2143 2150 O
risk 30 34 2151 2155 O
factors 35 42 2156 2163 O
involving 43 52 2164 2173 O
any 53 56 2174 2177 O
of 57 59 2178 2180 O
the 60 63 2181 2184 O
major 64 69 2185 2190 O
organ 70 75 2191 2196 O
systems 76 83 2197 2204 O
such 84 88 2205 2209 O
that 89 93 2210 2214 O
the 94 97 2215 2218 O
investigator 98 110 2219 2231 O
considers 111 120 2232 2241 O
it 121 123 2242 2244 O
unsafe 124 130 2245 2251 O
for 131 134 2252 2255 O
the 135 138 2256 2259 O
patient 139 146 2260 2267 O
to 147 149 2268 2270 O
receive 150 157 2271 2278 O
FOLFOX 158 164 2279 2285 B-treatment
- 164 165 2285 2286 I-treatment
A 165 166 2286 2287 I-treatment

Patients 0 8 2288 2296 O
with 9 13 2297 2301 O
unstable 14 22 2302 2310 O
biliary 23 30 2311 2318 B-treatment
stents 31 37 2319 2325 I-treatment
or 38 40 2326 2328 O
with 41 45 2329 2333 O
plastic 46 53 2334 2341 B-treatment
stents 54 60 2342 2348 I-treatment
. 60 61 2348 2349 O
Information 62 73 2350 2361 O
on 74 76 2362 2364 O
type 77 81 2365 2369 O
of 82 84 2370 2372 O
stent 85 90 2373 2378 O
is 91 93 2379 2381 O
required 94 102 2382 2390 O
at 103 105 2391 2393 O
registration 106 118 2394 2406 O

Platelet 0 8 2407 2415 B-clinical_variable
count 9 14 2416 2421 I-clinical_variable
≥ 15 16 2422 2423 O
100,000 17 24 2424 2431 B-lower_bound
/ 24 25 2431 2432 I-lower_bound
mm3 25 28 2432 2435 I-lower_bound
( 29 30 2436 2437 O
transfusion 30 41 2437 2448 B-treatment
independent 42 53 2449 2460 O
, 53 54 2460 2461 O
defined 55 62 2462 2469 O
as 63 65 2470 2472 O
not 66 69 2473 2476 O
receiving 70 79 2477 2486 O
platelet 80 88 2487 2495 B-treatment
transfusions 89 101 2496 2508 I-treatment
within 102 108 2509 2515 O
7 109 110 2516 2517 B-upper_bound
days 111 115 2518 2522 I-upper_bound
prior 116 121 2523 2528 I-upper_bound
to 122 124 2529 2531 O
laboratory 125 135 2532 2542 O
sample 136 142 2543 2549 O
) 142 143 2549 2550 O

Post 0 4 2551 2555 O
- 4 5 2555 2556 O
menopausal 5 15 2556 2566 O
women 16 21 2567 2572 B-gender

Preexisting 0 11 2573 2584 O
neuropathy 12 22 2585 2595 B-chronic_disease
is 23 25 2596 2598 O
not 26 29 2599 2602 O
allowed 30 37 2603 2610 O
from 38 42 2611 2615 O
any 43 46 2616 2619 O
cause 47 52 2620 2625 O

Prior 0 5 2626 2631 O
hypersensitivity 6 22 2632 2648 O
to 23 25 2649 2651 O
Oxaliplatin 26 37 2652 2663 B-allergy_name
or 38 40 2664 2666 O
Abraxane 41 49 2667 2675 B-allergy_name
® 50 51 2676 2677 I-allergy_name
that 52 56 2678 2682 O
in 57 59 2683 2685 O
the 60 63 2686 2689 O
investigators 64 77 2690 2703 O
opinion 78 85 2704 2711 O
would 86 91 2712 2717 O
put 92 95 2718 2721 O
the 96 99 2722 2725 O
patient 100 107 2726 2733 O
at 108 110 2734 2736 O
risk 111 115 2737 2741 O
if 116 118 2742 2744 O
re 119 121 2745 2747 O
- 121 122 2747 2748 O
exposed 122 129 2748 2755 O

Total 0 5 2756 2761 B-clinical_variable
bilirubin 6 15 2762 2771 I-clinical_variable
< 16 17 2772 2773 O
1 17 18 2773 2774 B-upper_bound
. 18 19 2774 2775 I-upper_bound
5 20 21 2776 2777 I-upper_bound
x 22 23 2778 2779 I-upper_bound
ULN 24 27 2780 2783 I-upper_bound

Uncontrolled 0 12 2784 2796 O
diabetes 13 21 2797 2805 B-chronic_disease
. 21 22 2805 2806 O
If 23 25 2807 2809 O
patient 26 33 2810 2817 O
has 34 37 2818 2821 O
diabetes 38 46 2822 2830 O
, 46 47 2830 2831 O
confirmation 48 60 2832 2844 O
on 61 63 2845 2847 O
status 64 70 2848 2854 O
( 71 72 2855 2856 O
controlled 72 82 2856 2866 O
or 83 85 2867 2869 O
uncontrolled 86 98 2870 2882 O
) 98 99 2882 2883 O
required 100 108 2884 2892 O
at 109 111 2893 2895 O
registration 112 124 2896 2908 O

Women 0 5 2909 2914 B-gender
of 6 8 2915 2917 O
child 9 14 2918 2923 O
bearing 15 22 2924 2931 O
potential 23 32 2932 2941 O
must 33 37 2942 2946 O
have 38 42 2947 2951 O
a 43 44 2952 2953 O
negative 45 53 2954 2962 B-pregnancy
serum 54 59 2963 2968 I-pregnancy
or 60 62 2969 2971 I-pregnancy
urine 63 68 2972 2977 I-pregnancy
pregnancy 69 78 2978 2987 I-pregnancy
test 79 83 2988 2992 O
( 84 85 2993 2994 O
minimum 85 92 2994 3001 O
sensitivity 93 104 3002 3013 B-clinical_variable
25 105 107 3014 3016 B-lower_bound
IU 108 110 3017 3019 I-lower_bound
/ 110 111 3019 3020 I-lower_bound
L 111 112 3020 3021 I-lower_bound
or 113 115 3022 3024 I-lower_bound
equivalent 116 126 3025 3035 I-lower_bound
units 127 132 3036 3041 I-lower_bound
of 133 135 3042 3044 I-lower_bound
HCG 136 139 3045 3048 I-lower_bound
) 139 140 3048 3049 O
within 141 147 3050 3056 O
7 148 149 3057 3058 B-upper_bound
days 150 154 3059 3063 I-upper_bound
prior 155 160 3064 3069 I-upper_bound
to 161 163 3070 3072 O
beginning 164 173 3073 3082 O
of 174 176 3083 3085 O
treatment 177 186 3086 3095 B-treatment

Women 0 5 3096 3101 B-gender
of 6 8 3102 3104 O
childbearing 9 21 3105 3117 O
potential 22 31 3118 3127 O
and 32 35 3128 3131 O
sexually 36 44 3132 3140 O
active 45 51 3141 3147 O
males 52 57 3148 3153 B-gender
must 58 62 3154 3158 O
use 63 66 3159 3162 B-contraception_consent
an 67 69 3163 3165 I-contraception_consent
effective 70 79 3166 3175 I-contraception_consent
contraception 80 93 3176 3189 I-contraception_consent
method 94 100 3190 3196 O
28 101 103 3197 3199 B-upper_bound
days 104 108 3200 3204 I-upper_bound
prior 109 114 3205 3210 I-upper_bound
to 115 117 3211 3213 O
treatment 118 127 3214 3223 B-treatment
, 127 128 3223 3224 O
during 129 135 3225 3231 O
treatment 136 145 3232 3241 O
and 146 149 3242 3245 O
for 150 153 3246 3249 O
three 154 159 3250 3255 B-upper_bound
months 160 166 3256 3262 I-upper_bound
after 167 172 3263 3268 I-upper_bound
completing 173 183 3269 3279 O
treatment 184 193 3280 3289 O
( 194 195 3290 3291 O
men 195 198 3291 3294 O
are 199 202 3295 3298 O
to 203 205 3299 3301 O
use 206 209 3302 3305 B-contraception_consent
contraception 210 223 3306 3319 I-contraception_consent
for 224 227 3320 3323 O
six 228 231 3324 3327 B-upper_bound
months 232 238 3328 3334 I-upper_bound
post 239 243 3335 3339 O
last 244 248 3340 3344 O
dose 249 253 3345 3349 O
of 254 256 3350 3352 O
drug 257 261 3353 3357 B-treatment
) 261 262 3357 3358 O
. 262 263 3358 3359 O
Documentation 264 277 3360 3373 O
of 278 280 3374 3376 O
this 281 285 3377 3381 O
being 286 291 3382 3387 O
discussed 292 301 3388 3397 O
required 302 310 3398 3406 O

do 0 2 3407 3409 O
not 3 6 3410 3413 O
need 7 11 3414 3418 O
to 12 14 3419 3421 O
have 15 19 3422 3426 O
a 20 21 3427 3428 O
pregnancy 22 31 3429 3438 B-pregnancy
test 32 36 3439 3443 O

surgical 0 8 3444 3452 B-clinical_variable
menopause 9 18 3453 3462 I-clinical_variable
or 19 21 3463 3465 I-clinical_variable
lack 22 26 3466 3470 I-clinical_variable
of 27 29 3471 3473 I-clinical_variable
menses 30 36 3474 3480 I-clinical_variable
> 37 38 3481 3482 O
24 38 40 3482 3484 B-lower_bound
months 41 47 3485 3491 I-lower_bound

